Last reviewed · How we verify
diazepam 20 mg
diazepam 20 mg is a Small molecule drug developed by Viatris Specialty LLC. It is currently FDA-approved.
Diazepam 20 mg, marketed by Viatris Specialty LLC, holds a significant position in the pharmaceutical market with a key composition patent expiring in 2028. The drug's primary strength lies in its well-established mechanism and broad therapeutic use, which has contributed to its sustained market presence. The primary risk is the potential increase in competition following the patent expiry in 2028, which could impact revenue and market share.
At a glance
| Generic name | diazepam 20 mg |
|---|---|
| Sponsor | Viatris Specialty LLC |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- TEAS for Sedation During ERCP: A Multicenter Trial (NA)
- Erector Spinae Plane Block vs Quadratus Lumborum Block for Laparoscopic Nephrectomy (NA)
- Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial (PHASE4)
- Acupuncture for Vasectomy Pre-procedural Anxiety and Pain Control in the Primary Care Setting (NA)
- Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine (PHASE2)
- Evaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience (PHASE4)
- Efficacy of SMOF Lipid in the Management of Acute Poisoning With Clozapine (PHASE2)
- Virtual Reality to Reduce Periprocedural Anxiety During Invasive Coronary Angiography (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- diazepam 20 mg CI brief — competitive landscape report
- diazepam 20 mg updates RSS · CI watch RSS
- Viatris Specialty LLC portfolio CI
Frequently asked questions about diazepam 20 mg
What is diazepam 20 mg?
Who makes diazepam 20 mg?
What development phase is diazepam 20 mg in?
Related
- Manufacturer: Viatris Specialty LLC — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing